Vensana Capital
Vensana Capital is a venture capital and growth equity firm that invests in development- and commercial-stage companies across the medtech sector. The firm provides capital and partnership to entrepreneurs working in medical devices, diagnostics and data science, drug delivery, digital health, life-science tools, and tech-enabled services.
Vensana Capital
Minneapolis, Minnesota, United States, North America
Services
Equity and growth capital
Provides venture capital and growth equity investments for development- and commercial-stage medtech companies.
Commercialization support
Support for driving U.S. commercial product launches and commercialization activities.
Strategic and board-level partnership
Board-level engagement and strategic guidance to management teams, including assistance with fundraising and strategic financings.
Regulatory and clinical support
Support related to regulatory pathways and clinical development, including activity leading to FDA PMA, de novo 510(k) and Level I clinical trials as relevant to portfolio companies.
Network and industry access
Access to Vensana’s industry network, including introductions to commercial, clinical and financial partners.
Equity and growth capital
Provides venture capital and growth equity investments for development- and commercial-stage medtech companies.
Commercialization support
Support for driving U.S. commercial product launches and commercialization activities.
Strategic and board-level partnership
Board-level engagement and strategic guidance to management teams, including assistance with fundraising and strategic financings.
Regulatory and clinical support
Support related to regulatory pathways and clinical development, including activity leading to FDA PMA, de novo 510(k) and Level I clinical trials as relevant to portfolio companies.
Network and industry access
Access to Vensana’s industry network, including introductions to commercial, clinical and financial partners.
Portfolio
Vensana participated in a $25 million financing to support commercialization of the Tack Endovascular System.
#Endovascular medical device
Vensana participated in a $37 million financing with Gilde Healthcare to complete development of the Duo Venous Stent System.
#Venous stent / vascular medical device
Reported $75 million Series D financing to advance a long-term drug delivery platform for glaucoma patients (linked from Vensana site news listing).
#Drug delivery / ophthalmology
Vensana participated in a $25 million financing to support commercialization of the Tack Endovascular System.
#Endovascular medical device
Vensana participated in a $37 million financing with Gilde Healthcare to complete development of the Duo Venous Stent System.
#Venous stent / vascular medical device
Reported $75 million Series D financing to advance a long-term drug delivery platform for glaucoma patients (linked from Vensana site news listing).
#Drug delivery / ophthalmology